Cancer
Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells.
Mudhasani R, Zhu Z, Hutvagner G, Eischen CM, Lyle S, Hall LL, Lawrence JB, Imbalzano AN, Jones SN.
J Cell Biol. 2008 Jun 30;181(7):1055-63.
MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2).
Kim S, Lee UJ, Kim MN, Lee EJ, Kim JY, Lee MY, Choung S, Kim YJ, Choi YC.
J Biol Chem. 2008 Jun 27;283(26):18158-66.
[Down-regulative expression of microRNAs cluster in human colon tumorigenesis]
Ba Y, Cai X, Chen X, Yin Y, Zhang Y, Zhang CY.
Zhonghua Yi Xue Za Zhi. 2008 Jun 24;88(24):1683-6.
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G,
Weiss WA, Alvarez-Buylla A, Hodgson JG.
BMC Med. 2008 Jun 24;6:14.
MicroRNAs: regulators of oncogenesis and stemness.
Papagiannakopoulos T, Kosik KS.
BMC Med. 2008 Jun 24;6:15.
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer.
Garofalo M, Quintavalle C, Di Leva G, Zanca C, Romano G, Taccioli C, Liu CG, Croce CM, Condorelli G.
Oncogene. 2008 Jun 19;27(27):3845-55.
Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer.
Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD, Washington MK, Paraskeva C, Willson JK, Kaz AM, Kroh EM, Allen A,
Fritz BR, Markowitz SD, Tewari M.
Oncogene. 2008 Jun 19;27(27):3880-8.
MicroRNA expression and identification of putative miRNA targets in ovarian cancer.
Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih IeM, Zhang Y, Wood W 3rd, Becker KG, Morin PJ.
PLoS ONE. 2008 Jun 18;3(6):e2436.
MicroRNA expression in colon adenocarcinoma.
Kida Y, Han YP.
JAMA. 2008 Jun 11;299(22):2628.
The E2F3-Oncomir-1 axis is activated in Wilms' tumor.
Kort EJ, Farber L, Tretiakova M, Petillo D, Furge KA, Yang XJ, Cornelius A, Teh BT.
Cancer Res. 2008 Jun 1;68(11):4034-8.
Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T.
Cancer Res. 2008 Jun 1;68(11):4123-32.
microRNAs and death receptors.
Park SM, Peter ME.
Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):303-11.
[MiR-9 regulates the expression of CBX7 in human glioma]
Chao TF, Zhang Y, Yan XQ, Yin B, Gong YH, Yuan JG, Qiang BQ, Peng XZ.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Jun;30(3):268-74.
[Recent progress on miRNAs in the pathogenesis of colon cancer]
Tang JT, Fang JY.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Jun;25(3):297-9.
Cancerous miRNAs and their regulation.
Shi XB, Tepper CG, deVere White RW.
Cell Cycle. 2008 Jun;7(11):1529-38.
Sex-specific microRNAome deregulation in the shielded bystander spleen of cranially exposed mice.
Koturbash I, Zemp FJ, Kutanzi K, Luzhna L, Loree J, Kolb B, Kovalchuk O.
Cell Cycle. 2008 Jun;7(11):1658-67.
Kallikreins as microRNA targets: an in silico and experimental-based analysis.
Chow TF, Crow M, Earle T, El-Said H, Diamandis EP, Yousef GM.
Biol Chem. 2008 Jun;389(6):731-8.
microRNAs: a new frontier in kallikrein research.
Yousef GM.
Biol Chem. 2008 Jun;389(6):689-94.
Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of Dicer
expression.
Chiosea SI, Barnes EL, Lai SY, Egloff AM, Sargent RL, Hunt JL, Seethala RR.
Virchows Arch. 2008 Jun;452(6):629-35.
A new regulatory loop in cancer-cell invasion.
Ocaña OH, Nieto MA.
EMBO Rep. 2008 Jun;9(6):521-2.
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.
Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T.
EMBO Rep. 2008 Jun;9(6):582-9.
Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling.
Worley LA, Long MD, Onken MD, Harbour JW.
Melanoma Res. 2008 Jun;18(3):184-90.
MicroRNAs and cancer epigenetics.
Fabbri M.
Curr Opin Investig Drugs. 2008 Jun;9(6):583-90.
Genome-wide studies in thyroid neoplasia.
Giordano TJ.
Endocrinol Metab Clin North Am. 2008 Jun;37(2):311-31, vii-viii.
Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium.
Marsh EE, Lin Z, Yin P, Milad M, Chakravarti D, Bulun SE.
Fertil Steril. 2008 Jun;89(6):1771-6.
MicroRNAs and lymphomas.
Croce CM.
Ann Oncol. 2008 Jun;19 Suppl 4:iv39-40.
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.
Weiss GJ, Bemis LT, Nakajima E, Sugita M, Birks DK, Robinson WA, Varella-Garcia M, Bunn PA Jr, Haney J, Helfrich BA, Kato H, Hirsch
FR, Franklin WA.
Ann Oncol. 2008 Jun;19(6):1053-9.
EGFR regulation by microRNA in lung cancer: a rose by any other name ... is an increasingly complicated rose.
Hayes DN, McLeod HL.
Ann Oncol. 2008 Jun;19(6):1036-7.
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J.
Hepatology. 2008 Jun;47(6):1955-63.
MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors.
Braconi C, Patel T.
Hepatology. 2008 Jun;47(6):1807-9.
MicroRNA expression profiles of human leukemias.
Takada S, Yamashita Y, Berezikov E, Hatanaka H, Fujiwara SI, Kurashina K, Watanabe H, Enomoto M, Soda M, Choi YL, Mano H.
Leukemia. 2008 Jun;22(6):1274-8.
T(3;7)(q27;q32) fuses BCL6 to a non-coding region at FRA7H near miR-29.
Schneider B, Nagel S, Kaufmann M, Winkelmann S, Bode J, Drexler HG, MacLeod RA.
Leukemia. 2008 Jun;22(6):1262-6.
MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications.
Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GA.
Leukemia. 2008 Jun;22(6):1095-105.
Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.
Takakura S, Mitsutake N, Nakashima M, Namba H, Saenko VA, Rogounovitch TI, Nakazawa Y, Hayashi T, Ohtsuru A, Yamashita S.
Cancer Sci. 2008 Jun;99(6):1147-54.
Linking miRNA regulation to BCR-ABL expression: the next dimension.
Faber J, Gregory RI, Armstrong SA.
Cancer Cell. 2008 Jun;13(6):467-9.
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression.
Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J, Malumbres M.
Cancer Cell. 2008 Jun;13(6):496-506.
The role of insulin receptor substrate-1 in transformation by v-src.
Sun H, Baserga R.
J Cell Physiol. 2008 Jun;215(3):725-32.
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional
repressors ZEB1 and ZEB2.
Korpal M, Lee ES, Hu G, Kang Y.
J Biol Chem. 2008 May 30;283(22):14910-4.
MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia.
Jongen-Lavrencic M, Sun SM, Dijkstra MK, Valk PJ, Löwenberg B.
Blood. 2008 May 15;111(10):5078-85.
microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.
Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, Purow B.
Cancer Res. 2008 May 15;68(10):3566-72.
Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia.
Dixon-McIver A, East P, Mein CA, Cazier JB, Molloy G, Chaplin T, Andrew Lister T, Young BD, Debernardi S.
PLoS ONE. 2008 May 14;3(5):e2141.
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K, Johnstone CN, Megraw
MS, Adams S, Lassus H, Huang J, Kaur S, Liang S, Sethupathy P, Leminen A, Simossis VA, Sandaltzopoulos R, Naomoto Y, Katsaros D,
Gimotty PA, DeMichele A, Huang Q, Bützow R, Rustgi AK, Weber BL, Birrer MJ, Hatzigeorgiou AG, Croce CM, Coukos G.
Proc Natl Acad Sci U S A. 2008 May 13;105(19):7004-9.
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a
microRNA-224-specific target.
Wang Y, Lee AT, Ma JZ, Wang J, Ren J, Yang Y, Tantoso E, Li KB, Ooi LL, Tan P, Lee CG.
J Biol Chem. 2008 May 9;283(19):13205-15.
Altered MicroRNA expression in cervical carcinomas.
Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, Bae DS.
Clin Cancer Res. 2008 May 1;14(9):2535-42.
Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue.
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI.
Clin Cancer Res. 2008 May 1;14(9):2588-92.
MicroRNA expression profiles in serous ovarian carcinoma.
Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, Kim JW, Kim S.
Clin Cancer Res. 2008 May 1;14(9):2690-5.
Gene expression profiling for the diagnosis and prognosis of acute myeloid leukaemia.
Mills K.
Front Biosci. 2008 May 1;13:4605-16.
Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia.
Hackanson B, Bennett KL, Brena RM, Jiang J, Claus R, Chen SS, Blagitko-Dorfs N, Maharry K, Whitman SP, Schmittgen TD, Lübbert M,
Marcucci G, Bloomfield CD, Plass C.
Cancer Res. 2008 May 1;68(9):3142-51.
Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce
senescence.
Kumamoto K, Spillare EA, Fujita K, Horikawa I, Yamashita T, Appella E, Nagashima M, Takenoshita S, Yokota J, Harris CC.
Cancer Res. 2008 May 1;68(9):3193-203.
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
Marcucci G, Radmacher MD, Maharry K, Mrózek K, Ruppert AS, Paschka P, Vukosavljevic T, Whitman SP, Baldus CD, Langer C, Liu CG,
Carroll AJ, Powell BL, Garzon R, Croce CM, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD.
N Engl J Med. 2008 May 1;358(18):1919-28.
Diagnosis and prognosis in acute myeloid leukemia--the art of distinction.
Löwenberg B.
N Engl J Med. 2008 May 1;358(18):1960-2.
Small RNAs and cancerogenesis.
Ryazansky SS, Gvozdev VA.
Biochemistry (Mosc). 2008 May;73(5):514-27.
Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target
genes with a role in B-cell neoplasia.
Ferreira BI, García JF, Suela J, Mollejo M, Camacho FI, Carro A, Montes S, Piris MA, Cigudosa JC.
Haematologica. 2008 May;93(5):670-9.
let-7 microRNA expression and the distinction between nonmucinous and mucinous bronchioloalveolar carcinomas.
Garfield D.
Lung Cancer. 2008 May;60(2):307.
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ, Brodeur GM, Maris JM.
Mol Cancer Res. 2008 May;6(5):735-42.
MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth.
Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M.
Cell Res. 2008 May;18(5):549-57.
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.
Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS,
Harris AL.
Br J Haematol. 2008 May;141(5):672-5.
Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome.
Pezzolesi MG, Platzer P, Waite KA, Eng C.
Am J Hum Genet. 2008 May;82(5):1141-9.
New insights into germ cell tumor formation.
Jessberger R.
Horm Metab Res. 2008 May;40(5):342-6.
miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155
expression.
Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G, Blokzijl T, Kooistra K, van T'veer MB, Rosati S, Visser L,
Jongen-Lavrencic M, Kluin PM, van den Berg A.
J Pathol. 2008 May;215(1):13-20.
Downregulation of microRNA-142 by proto-oncogene LMO2 and its co-factors.
Yuan W, Sun W, Yang S, Du J, Zhai CL, Wang ZQ, Zhang J, Zhu TH.
Leukemia. 2008 May;22(5):1067-71.
MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility.
Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE.
J Clin Endocrinol Metab. 2008 May;93(5):1600-8.
Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest.
Sun F, Fu H, Liu Q, Tie Y, Zhu J, Xing R, Sun Z, Zheng X.
FEBS Lett. 2008 Apr 30;582(10):1564-8.
Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, D'Arcy T, McGuinness E, Sheils O,
Sheppard B, O' Leary J.
Mol Cancer. 2008 Apr 28;7:35.
[Role of silencing PRL-3 expression by miRNA interference in the growth of gastric cancer]
Cai SR, Wang Z, Chen CQ, Cui J, Zhang CH, He YL, Zhan WH.
Zhonghua Wai Ke Za Zhi. 2008 Apr 15;46(8):618-21.
MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins.
Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, Chen CJ, Hildesheim A, Sugden B, Ahlquist P.
Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5874-8.
Identification of let-7-regulated oncofetal genes.
Boyerinas B, Park SM, Shomron N, Hedegaard MM, Vinther J, Andersen JS, Feig C, Xu J, Burge CB, Peter ME.
Cancer Res. 2008 Apr 15;68(8):2587-91.
MicroRNAs 221 and 222 bypass quiescence and compromise cell survival.
Medina R, Zaidi SK, Liu CG, Stein JL, van Wijnen AJ, Croce CM, Stein GS.
Cancer Res. 2008 Apr 15;68(8):2773-80.
Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.
Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K, Mori M.
Clin Cancer Res. 2008 Apr 15;14(8):2334-40.
The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic
mechanisms.
Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini M, Colombo MP, Peschle C, Carè A.
Cancer Res. 2008 Apr 15;68(8):2745-54.
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and
metastasis in colorectal cancer.
Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H.
Oncogene. 2008 Apr 3;27(15):2128-36.
An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer.
Salter KH, Acharya CR, Walters KS, Redman R, Anguiano A, Garman KS, Anders CK, Mukherjee S, Dressman HK, Barry WT, Marcom
KP, Olson J, Nevins JR, Potti A.
PLoS ONE. 2008 Apr 2;3(4):e1908.
Bioluminescence-based detection of microRNA, miR21 in breast cancer cells.
Cissell KA, Rahimi Y, Shrestha S, Hunt EA, Deo SK.
Anal Chem. 2008 Apr 1;80(7):2319-25.
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
Park SM, Gaur AB, Lengyel E, Peter ME.
Genes Dev. 2008 Apr 1;22(7):894-907.
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J.
Cancer Res. 2008 Apr 1;68(7):2094-105.
MiR-15a and miR-16-1 cluster functions in human leukemia.
Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI, Alder H, Volinia S,
Rassenti L, Liu X, Liu CG, Kipps TJ, Negrini M, Croce CM.
Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5166-71.
The role of microRNAs in primary liver cancer.
Varnholt H.
Ann Hepatol. 2008 Apr-Jun;7(2):104-13.
Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma.
Peng Y, Laser J, Shi G, Mittal K, Melamed J, Lee P, Wei JJ.
Mol Cancer Res. 2008 Apr;6(4):663-73.
miRNAs: Little known mediators of oncogenesis.
Gartel AL, Kandel ES.
Semin Cancer Biol. 2008 Apr;18(2):103-10.
The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
Stenvang J, Silahtaroglu AN, Lindow M, Elmen J, Kauppinen S.
Semin Cancer Biol. 2008 Apr;18(2):89-102.
Changes in miRNA expression in solid tumors: an miRNA profiling in melanomas.
Molnár V, Tamási V, Bakos B, Wiener Z, Falus A.
Semin Cancer Biol. 2008 Apr;18(2):111-22.
MicroRNAs accurately identify cancer tissue origin.
Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y,
Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M,
Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, Bentwich Z, Cohen D, Chajut A, Barshack I.
Nat Biotechnol. 2008 Apr;26(4):462-9.
Cancer biomarker profiling with microRNAs.
Jeffrey SS.
Nat Biotechnol. 2008 Apr;26(4):400-1.
MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression.
Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, Kobayashi SV, Lim L, Burchard J, Jackson AL, Linsley PS, Cleary
MA.
Mol Cell Biol. 2008 Apr;28(7):2167-74.
MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.
Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP, Odenthal M.
Hepatology. 2008 Apr;47(4):1223-32.
MicroRNAs and cancer.
Dalmay T.
J Intern Med. 2008 Apr;263(4):366-75.
MicroRNA expression signature of human sarcomas.
Subramanian S, Lui WO, Lee CH, Espinosa I, Nielsen TO, Heinrich MC, Corless CL, Fire AZ, van de Rijn M.
Oncogene. 2008 Mar 27;27(14):2015-26.
p16(INK4a) translation suppressed by miR-24.
Lal A, Kim HH, Abdelmohsen K, Kuwano Y, Pullmann R Jr, Srikantan S, Subrahmanyam R, Martindale JL, Yang X, Ahmed F, Navarro F,
Dykxhoorn D, Lieberman J, Gorospe M.
PLoS ONE. 2008 Mar 26;3(3):e1864.
The let-7 microRNA reduces tumor growth in mouse models of lung cancer.
Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, Weidhaas JB, Brown D, Bader AG, Slack FJ.
Cell Cycle. 2008 Mar 15;7(6):759-64.
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.
Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K, Alder H, Nakamura T, Flomenberg
N, Marcucci G, Calin GA, Kornblau SM, Kantarjian H, Bloomfield CD, Andreeff M, Croce CM.
Blood. 2008 Mar 15;111(6):3183-9.
Widespread deregulation of microRNA expression in human prostate cancer.
Ozen M, Creighton CJ, Ozdemir M, Ittmann M.
Oncogene. 2008 Mar 13;27(12):1788-93.
Epigenetics in cancer.
Esteller M.
N Engl J Med. 2008 Mar 13;358(11):1148-59.
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin.
Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, Volinia S, Liu CG, Schnittger S, Haferlach T, Liso A,
Diverio D, Mancini M, Meloni G, Foa R, Martelli MF, Mecucci C, Croce CM, Falini B.
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3945-50.
Suppression of non-small cell lung tumor development by the let-7 microRNA family.
Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, Jacks T.
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3903-8.
hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.
Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, Ragoussis J.
Clin Cancer Res. 2008 Mar 1;14(5):1340-8.
MicroRNA expression profiling in classic Hodgkin lymphoma.
Navarro A, Gaya A, Martinez A, Urbano-Ispizua A, Pons A, Balagué O, Gel B, Abrisqueta P, Lopez-Guillermo A, Artells R, Montserrat E,
Monzo M.
Blood. 2008 Mar 1;111(5):2825-32.
MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines.
Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, Coffey DG, Erickson PF, Shellman YG, Robinson WA.
Cancer Res. 2008 Mar 1;68(5):1362-8.
EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3.
Xia T, O'Hara A, Araujo I, Barreto J, Carvalho E, Sapucaia JB, Ramos JC, Luz E, Pedroso C, Manrique M, Toomey NL, Brites C, Dittmer
DP, Harrington WJ Jr.
Cancer Res. 2008 Mar 1;68(5):1436-42.
MicroRNA epigenetic alterations in human cancer: one step forward in diagnosis and treatment.
Yang N, Coukos G, Zhang L.
Int J Cancer. 2008 Mar 1;122(5):963-8.
MicroRNAs and cancer: profile, profile, profile.
Barbarotto E, Schmittgen TD, Calin GA.
Int J Cancer. 2008 Mar 1;122(5):969-77.
miR-21 microRNA expression in human gastric carcinomas and its clinical association.
Chan SH, Wu CW, Li AF, Chi CW, Lin WC.
Anticancer Res. 2008 Mar-Apr;28(2A):907-11.
Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and
invasiveness of prostate cancer LNCaP cells.
Musiyenko A, Bitko V, Barik S.
J Mol Med. 2008 Mar;86(3):313-22.
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.
Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY.
Cell Res. 2008 Mar;18(3):350-9.
Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells.
Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R.
Mol Cancer Ther. 2008 Mar;7(3):464-73.
MicroRNAs in malignant progression.
Ma L, Weinberg RA.
Cell Cycle. 2008 Mar;7(5):570-2.
E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer.
Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, Cavazzini L, Volinia S,
Alder H, Ruco LP, Baldassarre G, Croce CM, Vecchione A.
Cancer Cell. 2008 Mar;13(3):272-86.
Identification of metastasis-related microRNAs in hepatocellular carcinoma.
Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, Tang ZY, Wang XW.
Hepatology. 2008 Mar;47(3):897-907.
Loss of mir-146a function in hormone-refractory prostate cancer.
Lin SL, Chiang A, Chang D, Ying SY.
RNA. 2008 Mar;14(3):417-24.
Gene alteration and precursor and mature microRNA transcription changes contribute to the miRNA signature of primary effusion
lymphoma.
O'Hara AJ, Vahrson W, Dittmer DP.
Blood. 2008 Feb 15;111(4):2347-53.
Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
Ouillette P, Erba H, Kujawski L, Kaminski M, Shedden K, Malek SN.
Cancer Res. 2008 Feb 15;68(4):1012-21.
Cancer proliferation gene discovery through functional genomics.
Schlabach MR, Luo J, Solimini NL, Hu G, Xu Q, Li MZ, Zhao Z, Smogorzewska A, Sowa ME, Ang XL, Westbrook TF, Liang AC, Chang K,
Hackett JA, Harper JW, Hannon GJ, Elledge SJ.
Science. 2008 Feb 1;319(5863):620-4.
MYCN regulates oncogenic MicroRNAs in neuroblastoma.
Schulte JH, Horn S, Otto T, Samans B, Heukamp LC, Eilers UC, Krause M, Astrahantseff K, Klein-Hitpass L, Buettner R, Schramm A,
Christiansen H, Eilers M, Eggert A, Berwanger B.
Int J Cancer. 2008 Feb 1;122(3):699-704.
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer.
Giannakakis A, Sandaltzopoulos R, Greshock J, Liang S, Huang J, Hasegawa K, Li C, O'Brien-Jenkins A, Katsaros D, Weber BL, Simon
C, Coukos G, Zhang L.
Cancer Biol Ther. 2008 Feb;7(2):255-64.
Hypoxic regulation of miR-210: shrinking targets expand HIF-1's influence.
Corn PG.
Cancer Biol Ther. 2008 Feb;7(2):265-7.
Meeting report: fourth international congress of the Society for Melanoma Research.
Fisher DE, Medrano EE, McMahon M, Soengas MS, Schuchter L, Wolchok JD, Merlino G.
Pigment Cell Melanoma Res. 2008 Feb;21(1):15-26.
[microRNA in cancer, small but risky]
Puisieux A, Ansieau S.
Med Sci (Paris). 2008 Feb;24(2):135-6.
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.
Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, Gimotty PA, Katsaros D,
Coukos G, Zhang L, Puré E, Agami R.
Nat Cell Biol. 2008 Feb;10(2):202-10.
Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma.
Rai D, Karanti S, Jung I, Dahia PL, Aguiar RC.
Cancer Genet Cytogenet. 2008 Feb;181(1):8-15.
Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic
thyroid carcinoma cell lines.
Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N, Kato K, Komatsu
H, Ikeda K, Wakabayashi G, Masuda T.
Cancer Sci. 2008 Feb;99(2):280-6.
High-dimensional biology to comprehend hepatocellular carcinoma.
Vivekanandan P, Singh OV.
Expert Rev Proteomics. 2008 Feb;5(1):45-60.
The identification of microRNAs in a genomically unstable region of human chromosome 8q24.
Huppi K, Volfovsky N, Runfola T, Jones TL, Mackiewicz M, Martin SE, Mushinski JF, Stephens R, Caplen NJ.
Mol Cancer Res. 2008 Feb;6(2):212-21.
Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL
pathogenesis.
Marton S, Garcia MR, Robello C, Persson H, Trajtenberg F, Pritsch O, Rovira C, Naya H, Dighiero G, Cayota A.
Leukemia. 2008 Feb;22(2):330-8.
MicroRNA expression profiles of esophageal cancer.
Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, Swanson SJ, Godfrey TE, Litle VR.
J Thorac Cardiovasc Surg. 2008 Feb;135(2):255-60; discussion 260.
Oncogenes and cancer.
Croce CM.
N Engl J Med. 2008 Jan 31;358(5):502-11.
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce
CM, Harris CC.
JAMA. 2008 Jan 30;299(4):425-36.
Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer.
Ohta M, Mimori K, Fukuyoshi Y, Kita Y, Motoyama K, Yamashita K, Ishii H, Inoue H, Mori M.
Br J Cancer. 2008 Jan 29;98(2):410-7.
Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.
Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, Roberts LR, Schmittgen TD.
Clin Cancer Res. 2008 Jan 15;14(2):419-27.
MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.
Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ.
Cancer Res. 2008 Jan 15;68(2):425-33.
Pvt1-encoded microRNAs in oncogenesis.
Beck-Engeser GB, Lum AM, Huppi K, Caplen NJ, Wang BB, Wabl M.
Retrovirology. 2008 Jan 14;5:4.
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.
Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH.
J Biol Chem. 2008 Jan 11;283(2):1026-33.
Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes.
Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T.
Oncogene. 2008 Jan 10;27(3):378-86.
Endogenous human microRNAs that suppress breast cancer metastasis.
Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massagué J.
Nature. 2008 Jan 10;451(7175):147-52.
Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells.
Chen R, Alvero AB, Silasi DA, Steffensen KD, Mor G.
Oncogene. 2008 Jan 7;27(2):225-33.
Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma.
Guo Y, Chen Z, Zhang L, Zhou F, Shi S, Feng X, Li B, Meng X, Ma X, Luo M, Shao K, Li N, Qiu B, Mitchelson K, Cheng J, He J.
Cancer Res. 2008 Jan 1;68(1):26-33.
[RNA and cancer]
Jeanteur P.
Bull Cancer. 2008 Jan 1;95(1):33-41.
Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids.
Pan Q, Luo X, Chegini N.
J Cell Mol Med. 2008 Jan-Feb;12(1):227-40.
Oncoproteins, heterochromatin silencing and microRNAs: a new link for leukemogenesis.
Nervi C, Fazi F, Grignani F.
Epigenetics. 2008 Jan-Feb;3(1):1-4.
Molecular markers and targets for colorectal cancer prevention.
Janakiram NB, Rao CV.
Acta Pharmacol Sin. 2008 Jan;29(1):1-20.
MicroRNA: implications for cancer.
Sassen S, Miska EA, Caldas C.
Virchows Arch. 2008 Jan;452(1):1-10.
Identification of acute myeloid leukaemia associated microRNA expression patterns.
Isken F, Steffen B, Merk S, Dugas M, Markus B, Tidow N, Zühlsdorf M, Illmer T, Thiede C, Berdel WE, Serve H, Müller-Tidow C.
Br J Haematol. 2008 Jan;140(2):153-61.
MicroRNAs modulate the chemosensitivity of tumor cells.
Blower PE, Chung JH, Verducci JS, Lin S, Park JK, Dai Z, Liu CG, Schmittgen TD, Reinhold WC, Croce CM, Weinstein JN, Sadee W.
Mol Cancer Ther. 2008 Jan;7(1):1-9.
[Molecular genetic analysis for malignant gliomas: clinical implications and future directions]
Mizoguchi M, Shono T.
No Shinkei Geka. 2008 Jan;36(1):83-91.
Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis.
Huang YS, Dai Y, Yu XF, Bao SY, Yin YB, Tang M, Hu CX.
J Gastroenterol Hepatol. 2008 Jan;23(1):87-94.
Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.
Lehmann U, Hasemeier B, Christgen M, Müller M, Römermann D, Länger F, Kreipe H.
J Pathol. 2008 Jan;214(1):17-24.
MicroRNA signature predicts survival and relapse in lung cancer.
Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su
HY, Chen CC, Chen WJ, Liu CC, Chan WK, Chen WJ, Li KC, Chen JJ, Yang PC.
Cancer Cell. 2008 Jan;13(1):48-57.
Widespread microRNA repression by Myc contributes to tumorigenesis.
Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT.
Nat Genet. 2008 Jan;40(1):43-50.
Acute myeloid leukemia: the challenge of capturing disease variety.
Löwenberg B.
Hematology Am Soc Hematol Educ Program. 2008:1-11.
Regulatory mechanism of Bcl-2 in uterine leiomyomas.
Ohara N.
Clin Exp Obstet Gynecol. 2008;35(4):240-1.
The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice.
Mercatelli N, Coppola V, Bonci D, Miele F, Costantini A, Guadagnoli M, Bonanno E, Muto G, Frajese GV, De Maria R, Spagnoli LG,
Farace MG, Ciafrè SA.
PLoS ONE. 2008;3(12):e4029.
p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation.
Brosh R, Shalgi R, Liran A, Landan G, Korotayev K, Nguyen GH, Enerly E, Johnsen H, Buganim Y, Solomon H, Goldstein I, Madar S,
Goldfinger N, Børresen-Dale AL, Ginsberg D, Harris CC, Pilpel Y, Oren M, Rotter V.
Mol Syst Biol. 2008;4:229.
The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition.
Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest AR, Kolle G, Gabrielli B, Grimmond SM.
Genome Biol. 2008;9(8):R127.
PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes.
Git A, Spiteri I, Blenkiron C, Dunning MJ, Pole JC, Chin SF, Wang Y, Smith J, Livesey FJ, Caldas C.
Breast Cancer Res. 2008;10(3):R54.
Breast cancer metastasis: a microRNA story.
Negrini M, Calin GA.
Breast Cancer Res. 2008;10(2):203.
Distinct patterns in the regulation and evolution of human cancer genes.
Furney SJ, Madden SF, Kisiel TA, Higgins DG, Lopez-Bigas N.
In Silico Biol. 2008;8(1):33-46.
MicroRNA in human cancer: one step forward in diagnosis and treatment.
Zhang L, Yang N, Coukos G.
Adv Exp Med Biol. 2008;622:69-78.
Expression profiling of microRNAs in cancer cells: technical considerations.
Sioud M, Cekaite L.
Methods Mol Biol. 2008;439:179-90.
[The causes of cancer]
Zündorf I, Dingermann T.
Pharm Unserer Zeit. 2008;37(2):119.
Reasons for breast cancer heterogeneity.
Bertucci F, Birnbaum D.
J Biol. 2008;7(2):6.
[Involvement of microRNAs in cancer biology and possibilities of their application to diagnostic and predictive oncology]
Slabý O, Krekác D, Hrstka R, Svoboda M, Vyzula R.
Cas Lek Cesk. 2008;147(1):25-31.